Market Cap 154.50M P/E - EPS this Y 19.80% Ern Qtrly Grth -
Income -84.23M Forward P/E -2.26 EPS next Y 5.50% 50D Avg Chg -3.00%
Sales 10M PEG - EPS past 5Y - 200D Avg Chg -14.00%
Dividend N/A Price/Book 1.46 EPS next 5Y - 52W High Chg -59.00%
Recommedations 1.70 Quick Ratio 2.27 Shares Outstanding 99.04M 52W Low Chg 58.00%
Insider Own 14.69% ROA -16.19% Shares Float 76.54M Beta 1.41
Inst Own 33.12% ROE -59.96% Shares Shorted/Prior 6.24M/4.88M Price 1.56
Gross Margin -201.39% Profit Margin - Avg. Volume 2,554,622 Target Price 5.67
Oper. Margin -485.04% Earnings Aug 9 Volume 1,989,047 Change 14.71%
Abeona Therapeutics Inc. News
06:30 AM Abeona Therapeutics Reports First Quarter Financial Results
05/11/21 Moving Average Crossover Alert: Abeona Therapeutics (ABEO)
04/20/21 Abeona Therapeutics Announces Presentation on New Preclinical Data Supporting the Potential of Cre-Mediated Dual AAV Vector Technology to Enable Delivery of Large Genes Targeted for Treatment of Stargardt Disease at ARVO 2021 Annual Meeting
04/19/21 Abeona Therapeutics Appoints Two Industry Leaders as New Independent Members to Its Board of Directors
03/25/21 Abeona Therapeutics Announces Appointment of Two New Independent Members to its Board of Directors
03/24/21 Abeona Therapeutics (ABEO) Reports Q4 Loss, Lags Revenue Estimates
03/24/21 Abeona Therapeutics Announces 2020 Financial Results and Recent Operational Progress
03/23/21 SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Abeona Therapeutics Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
03/22/21 Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Executive Officer
03/11/21 Abeona Therapeutics' (NASDAQ:ABEO) Shareholders Are Down 85% On Their Shares
02/25/21 Billionaire Ken Griffin Pulls the Trigger on These 2 Penny Stocks
02/22/21 Abeona Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
02/12/21 New Positive Phase 1/2 Interim Data Presented at WORLDSymposium™ Shows Neurocognitive Development of Young MPS IIIA Patients Preserved up to Three Years Following Treatment with Abeona’s ABO-102 Gene Therapy
02/02/21 Abeona Therapeutics Announces Clinical Investigator Webinar to Review ABO-102 and ABO-101 Clinical Data Presented at the 17th Annual WORLDSymposium™
01/25/21 Abeona Therapeutics Announces Successful Type B Meeting with FDA for Pivotal Phase 3 VIITAL™ Study of EB-101 in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
01/12/21 Do Options Traders Know Something About Abeona (ABEO) Stock We Don't?
12/21/20 Abeona Therapeutics Announces Acceptance of Late-Breaker Abstracts Highlighting New Clinical Data for Novel AAV-based Gene Therapies in MPS IIIA and MPS IIIB at WORLDSymposium™
12/14/20 Is ABEO A Good Stock To Buy Now?
12/01/20 Verastem (VSTM) Begins Phase II Combo Study for Ovarian Cancer

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A; and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B. The company also develops ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten disease; ABO-401 for the treatment of cystic fibrosis; and ABO-5OX for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. Abeona Therapeutics Inc. has a license agreement with REGENXBIO Inc. for the development and commercialization of gene therapies for the treatment of MPS IIIA, MPS IIIB, CLN1 disease, and CLN3 disease. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.

ABEO Chatroom

User Image lewdog_5 Posted - 4 hours ago

$ABEO this should trend. $3-5 coming in next few months.

User Image WallStreetOdds_ Posted - 4 hours ago

$ABEO Out of the 43 other times ABEO was up 16.5% during a trading day, 58% of the time it traded lower by the same day's market close. wallstreetodds.com

User Image TragicBio Posted - 4 hours ago

$ABEO 16% today. Shiiii

User Image Abjo Posted - 4 hours ago

$ABEO Looking really nice. Broke out today and tok another level.

User Image MikeCaymanTrades Posted - 4 hours ago

$ABEO---Daily chart oversold. Could see 2.00 again.

User Image chotabhaiTwits Posted - 5 hours ago

$ABEO From ABEO earnings today "Net loss was $16.0 million for the first quarter of 2021, compared to net loss of $48.2 million for the comparable period in 2020. The decrease in net loss was primarily due to the non-cash impairment charge of $32.9 million related to the termination of the license agreement with REGENXBIO in the first quarter of 2020."

User Image PharmaExpert Posted - 6 hours ago

$AKBA, $ABEO, $POLA, $GME, $AMC

User Image pranami108 Posted - 6 hours ago

$VBIV coiling up for explosion $ABEO and $AGTC on move... $BCRX ready to shoot up. load up for sunny days ahead. Excellent summer for Bulls !!

User Image algoslingah Posted - 7 hours ago

$ABEO is up 12.0% from market open on 726,202 volume #tenpercentscan

User Image dredubz Posted - 8 hours ago

$ABEO lets gooo

User Image STCKPRO Posted - 10 hours ago

$ABEO NEW ARTICLE : Abeona Therapeutics EPS beats by $0.02 https://www.stck.pro/news/ABEO/12995346

User Image Estimize Posted - 10 hours ago

$ABEO beats the Estimize EPS Consensus by 2c and misses the Estimize Revenue Consensus by $0.30M. Reports FQ1 earnings of -17c EPS and ... http://www.estimize.com/abeo/fq1-2021?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image epsguid Posted - 10 hours ago

$ABEO reported a loss of $0.17, consensus was ($0.19) via @eWhispers #epsbeat http://eps.sh/d/abeo

User Image Quantisnow Posted - 10 hours ago

$ABEO 📜 SEC Form 8-K filed by Abeona Therapeutics Inc. https://quantisnow.com/insight/754538?s=s #majorpharmaceuticals #healthcare

User Image Newsfilter Posted - 10 hours ago

$ABEO Form 8-K: https://newsfilter.io/a/4b16f87ed9ce75c7fb953be89bc6eee0

User Image risenhoover Posted - 10 hours ago

Also, if you are new to $ABEO here's a background article on Finpedia for you https://finpedia.co/bin/Abeona%20Therapeutics/

User Image risenhoover Posted - 10 hours ago

$ABEO / Abeona Therapeutics files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 18, 2021 ABEONA THERAPEUTICS IN https://fintel.io/sf/us/abeo?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

User Image STCKPRO Posted - 10 hours ago

$ABEO NEW ARTICLE : Abeona Therapeutics Reports First Quarter Financial Results https://www.stck.pro/news/ABEO/12995233

User Image cctranscripts Posted - 10 hours ago

Abeona Therapeutics Reports First Quarter Financial Results https://conferencecalltranscripts.com/summary/?id=217937&pr=true $ABEO

User Image fla Posted - 10 hours ago

$ABEO [15s. delayed, acc.~90%, always check] Earnings Release May 18, 07:30:00: Q1: GAAP EPS of -$0.17 https://s.flashalert.me/SuI6DU

User Image fla Posted - 10 hours ago

$ABEO [15s. delayed]: Issued Press Release on May 18, 07:30:00: Abeona Therapeutics Reports First Quarter Financial Results https://s.flashalert.me/RtjnV

User Image ChartMill Posted - 11 hours ago

$ABEO: Abeona Therapeutics Reports First Quarter Financial Results https://www.chartmill.com/news/ABEO/globenews-2021-5-18-abeona-therapeutics-reports-first-quarter-financial-results?utm_source=stocktwits&utm_medium=pressRelease&utm_content=ABEO&utm_campaign=social_tracking

User Image Newsfilter Posted - 11 hours ago

$ABEO Abeona Therapeutics Reports First Quarter Financial Results https://newsfilter.io/a/e2d21c720a6bdcca83931c1f4c3bc428

User Image Quantisnow Posted - 11 hours ago

$ABEO 📰 Abeona Therapeutics Reports First Quarter Financial Results https://quantisnow.com/insight/754415?s=s #majorpharmaceuticals #healthcare

User Image Stock_Titan Posted - 11 hours ago

$ABEO Abeona Therapeutics Reports First Quarter Financial Results https://www.stocktitan.net/news/ABEO/abeona-therapeutics-reports-first-quarter-financial-dbj9kp08u44f.html

User Image risenhoover Posted - 1 day ago

$ABEO / Abeona Therapeutics files form 10-Q https://fintel.io/sf/us/abeo?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

User Image Quantisnow Posted - 1 day ago

$ABEO 📜 SEC Form 10-Q filed by Abeona Therapeutics Inc. https://quantisnow.com/insight/750942?s=s #majorpharmaceuticals #healthcare

User Image Newsfilter Posted - 1 day ago

$ABEO Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC https://newsfilter.io/a/6e2463c9460ae08bb588d08f1417fe5a

User Image BlackRockInvestment Posted - 1 day ago

$ABEO Institutions are betting big on this, hedge funds are betting big on this, daddy will be betting big on this 🤑 $5 by September!

User Image CZARBETS Posted - 1 day ago

$ABEO institutional ownership up 2.1% from 34.7% to 36.8%

Analyst Ratings
HC Wainwright & Co. Buy Nov 25, 20
Cantor Fitzgerald Overweight Nov 11, 20
SVB Leerink Outperform Nov 10, 20
B. Riley FBR Buy Sep 18, 20
RBC Capital Outperform May 8, 20
RBC Capital Outperform Mar 18, 20
SVB Leerink Outperform Feb 10, 20
H.C. Wainwright Buy Dec 30, 19
Maxim Group Hold Aug 15, 19
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own
Jan 19, 6:48 PM Sell 2.03 320,000 649,600 11,599,292
Mann Paul Elliot Director Director Jan 5, 7:07 PM Sell 1.54 30,488 46,952 132,664